alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5425 Introduced in House (IH)]

111th CONGRESS
  2d Session
                                H. R. 5425

  To amend the Patient Protection and Affordable Care Act to permit a 
  State to elect not to establish an American Health Benefit Exchange.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 27, 2010

 Mr. Fleming introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
  To amend the Patient Protection and Affordable Care Act to permit a 
  State to elect not to establish an American Health Benefit Exchange.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop the Federal Exchanges from 
Destroying States Act'' or the ``STOP the FEDS Act''.

SEC. 2. STATE OPT OUT FROM AMERICAN HEALTH BENEFIT EXCHANGE 
              REQUIREMENT.

    (a) In General.--Section 1311 of the Patient Protection and 
Affordable Care Act (Public Law 111-148) is amended by adding at the 
end the following new subsection:
    ``(l) State Opt Out.--
            ``(1) In general.--A State may elect not to establish any 
        required Exchange for the State (or to cease the operation of 
        all required Exchanges for the State) if the State enacts a law 
        that provides for such election.
            ``(2) Termination of opt out.--A State may repeal a law 
        described in paragraph (1) and provide for the establishment of 
        an Exchange for the State.''.
    (b) Conforming Amendments.--
            (1) Section 1311(b)(1) of the Patient Protection and 
        Affordable Care Act is amended by striking ``Each State'' and 
        inserting ``Subject to subsection (l), each State''.
            (2) Section 1321(c) of such Act is amended by adding at the 
        end the following sentence: ``The preceding sentence shall not 
        apply to a State that has in effect a law described in section 
        1311(l).''.
                                 <all>
```
<PAGE>

                                                                   EXHIBIT 10.46


                            STOCK PURCHASE AGREEMENT

                  This agreement is dated December 10, 2001 between ____________
("Purchaser"), and NeoTherapeutics, Inc. ("Company"), whereby the parties agree
as follows:

         The Purchaser shall buy and the Company agrees to sell _______ shares
("Shares") of the Company's Common Stock at a price of $3.85 per share for a
total amount of $___________. The Shares have been registered on a Form S-3,
File No. 333-53108, which registration statement has been declared effective by
the Securities and Exchange Commission. The Shares are free of restrictive
legends and are free of any resale restrictions. The Company is delivering
herewith a prospectus supplement on Form 424 (b)(2) regarding the sale of the
Shares prior to funding.

         The Purchaser shall wire the purchase amount to the Company to the
account set forth below.

Company Wire Transfer Instructions:

         Chase Manhattan Bank
         1 Chase Plaza
         New York, NY 10004
         ABA # 021 000 021
         FBO Salomon Smith Barney
         A/C # 066-198038
         For Further Credit to:
         Neotherapeutics, Inc.
         A/C # 561-04051-19-103

         The Company shall cause its transfer agent to transmit the Shares
electronically to the Purchaser by crediting the account set forth below through
the Deposit Withdrawal Agent Commission system.

Purchaser DWAC Instructions:

         --------------
         DTC #____
         --------------


<PAGE>

                                       2







                                    AGREED AND ACCEPTED:


                                    NeoTherapeutics, Inc.


                                    By:
                                       -----------------------------------------
                                       Name:
                                       Title:


                                    PURCHASER:

                                    [Purchaser Name]


                                    By:
                                       -----------------------------------------
                                       Name:
                                       Title:
<TABLE> <S> <C>


<ARTICLE>                                           7
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION EXTRACTED FROM FOR 10-Q FOR
THE SIX MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
</LEGEND>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-END>                                   JUN-30-1999
<DEBT-HELD-FOR-SALE>                           411,463
<DEBT-CARRYING-VALUE>                            2,695
<DEBT-MARKET-VALUE>                              2,269
<EQUITIES>                                       2,318
<MORTGAGE>                                      10,232
<REAL-ESTATE>                                   11,537
<TOTAL-INVEST>                                 684,452
<CASH>                                           9,688
<RECOVER-REINSURE>                              20,673
<DEFERRED-ACQUISITION>                          33,583
<TOTAL-ASSETS>                               1,348,583
<POLICY-LOSSES>                                132,994
<UNEARNED-PREMIUMS>                              2,110
<POLICY-OTHER>                                 537,406
<POLICY-HOLDER-FUNDS>                           10,730
<NOTES-PAYABLE>                                      0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,378
<OTHER-SE>                                     149,049
<TOTAL-LIABILITY-AND-EQUITY>                 1,348,583
<PREMIUMS>                                       5,158
<INVESTMENT-INCOME>                             25,875
<INVESTMENT-GAINS>                                   0
<OTHER-INCOME>                                   1,783
<BENEFITS>                                      16,594
<UNDERWRITING-AMORTIZATION>                      1,215
<UNDERWRITING-OTHER>                             8,354
<INCOME-PRETAX>                                  8,837
<INCOME-TAX>                                     3,249
<INCOME-CONTINUING>                              5,588
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,588
<EPS-BASIC>                                     0.64
<EPS-DILUTED>                                     0.64
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0



</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          32,818
<INT-BEARING-DEPOSITS>                         265,489
<FED-FUNDS-SOLD>                                15,770
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     94,353
<INVESTMENTS-CARRYING>                          36,790
<INVESTMENTS-MARKET>                           131,372
<LOANS>                                        199,895
<ALLOWANCE>                                      3,382
<TOTAL-ASSETS>                                 394,123
<DEPOSITS>                                     320,162
<SHORT-TERM>                                    21,802
<LIABILITIES-OTHER>                              3,664
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            29
<OTHER-SE>                                      48,465
<TOTAL-LIABILITIES-AND-EQUITY>                 394,123
<INTEREST-LOAN>                                 16,762
<INTEREST-INVEST>                                8,254
<INTEREST-OTHER>                                   450
<INTEREST-TOTAL>                                25,467
<INTEREST-DEPOSIT>                              11,164
<INTEREST-EXPENSE>                              11,619
<INTEREST-INCOME-NET>                           13,849
<LOAN-LOSSES>                                      310
<SECURITIES-GAINS>                                 (8)
<EXPENSE-OTHER>                                 16,452
<INCOME-PRETAX>                                  6,773
<INCOME-PRE-EXTRAORDINARY>                       6,773
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,520
<EPS-PRIMARY>                                     1.56
<EPS-DILUTED>                                     1.56
<YIELD-ACTUAL>                                    .040
<LOANS-NON>                                        173
<LOANS-PAST>                                       650
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                  1,902
<ALLOWANCE-OPEN>                                 3,356
<CHARGE-OFFS>                                      463
<RECOVERIES>                                       179
<ALLOWANCE-CLOSE>                                3,382
<ALLOWANCE-DOMESTIC>                             2,460
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            922


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [FEMA-3214-EM]

# AGENCY:

Federal Emergency Management Agency, Emergency Preparedness and Response Directorate, Department of Homeland Security.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of an emergency declaration for the State of Alabama (FEMA-3214-EM), dated August 28, 2005, and related determinations.

# EFFECTIVE DATE:

September 18, 2005.

# FOR FURTHER INFORMATION CONTACT:

Magda Ruiz, Recovery Division, Federal Emergency Management Agency, Washington, DC 20472, (202) 646-2705.

# SUPPLEMENTARY INFORMATION:

The Federal Emergency Management Agency (FEMA) hereby gives notice that pursuant to the authority vested in the Acting Under Secretary for Emergency Preparedness and Response, Department of Homeland Security, under Executive Order 12148, as amended, Michael Bolch of FEMA is appointed to act as the Federal Coordinating Officer for this declared emergency.

This action terminates my appointment of Ron Sherman as Federal Coordinating Officer for this emergency.

(The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund Program; 97.032, Crisis Counseling; 97.033, Disaster Legal Services Program; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance; 97.048, Individuals and Households Housing; 97.049, Individuals and Households Disaster Housing Operations; 97.050, Individuals and Households Program—Other Needs; 97.036, Public Assistance Grants; 97.039, Hazard Mitigation Grant Program.)

R. David Paulison,

Acting Under Secretary, Emergency Preparedness and Response, Department of Homeland Security.

[FR Doc. 05-21135 Filed 10-21-05; 8:45 am]

BILLING CODE 9110-10-P
Document

Exhibit 10.12

Summary of SmileDirectClub, Inc. 
Compensation for Non-Employee and Non-Affiliated Directors
(as of February 22, 2022)


Non-employee and non-affiliated directors of SmileDirectClub, Inc. (the “Company”) will receive compensation for their service as follows: 


•Each non-employee and non-affiliated director of the Company is eligible to receive an annual grant of restricted stock units (“RSUs”), with a grant date fair value of $300,000; for 2022, in order to transition the grant cycle to coincide with the Company’s annual stockholder meetings, each such director will receive an annual grant of RSUs on April 1, 2022, with a grant date fair value of $350,000 (the “2022 Annual Grant Value”), which grant will vest on the earlier of June 1, 2023 or the day before the date of the Company’s annual meeting of stockholders for 2023 (such earlier date, the “Vesting Date”), subject to the director’s continued service on the Company’s board of directors (“Board”) through the Vesting Date.


•Each new non-employee and non-affiliated director of the Company will receive a prorated initial grant of RSUs upon joining the Board to be determined based on the annual grant value; for 2022, such prorated grant will be determined by (i) multiplying the number of months remaining following the date of grant, including the onboarding month, through the Vesting Date, by the value of the annual grant, and (ii) dividing by 14, which grant will vest on the Vesting Date, subject to the director’s continued service on the Board through the Vesting Date.


•Non-employee and non-affiliated directors of the Company may elect to receive their annual RSU grant in the form of a restricted stock award, in lieu of RSUs, with the same value and vesting terms as the RSU grants.


The RSU awards (or restricted stock awards, as the case may be) are also subject to full vesting acceleration upon a change in control.  Each such director is entitled to reimbursement for all out-of-pocket expenses incurred in connection with attending each meeting of the Board and any committee thereof.
##### 



EXHIBIT 23 CONSENT OF CAWLEY, GILLESPIE & ASSOCIATES INC. [LETTERHEAD] March 14, 2005 Permian Basin Royalty Trust
Bank of America, N.A., Trustee
901 Main Street, 17th Floor
Dallas, Texas 75202-3714 Gentlemen: Cawley, Gillespie & Associates, Inc. hereby consents to the use of the oil and gas reserve
information in the Permian Basin Royalty Trust Securities and Exchange Commission Form 10-K for the
year ending December 31, 2004 and in the Permian Basin Royalty Trust Annual Report for the year
ending December 31, 2003, based on reserve reports dated February 25, 2005, prepared by Cawley,
Gillespie & Associates, Inc. Submitted,CAWLEY, GILLESPIE & ASSOCIATES, INC.By:
    
    /s/ KENNETH J. MVELLERKenneth J. Mveller, Vice President
# C_2007238EN.01000601.xml

| 10.10.2007 | EN | Official Journal of the European Union | C 238/6 |
| --- | --- | --- | --- |

10.10.2007

EN

Official Journal of the European Union

C 238/6

---

Non-opposition to a notified concentration

(Case COMP/M.4750 — Luvata/Eco)

(Text with EEA relevance)

(2007/C 238/04)

On 3 August 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(2) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32007M4750. EUR-Lex is the on-line access to European law (http://eur-lex.europa.eu). |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32007M4750. EUR-Lex is the on-line access to European law (http://eur-lex.europa.eu).

---
United States Department of Labor

Employees’ Compensation Appeals Board

__________________________________________

P.H., Appellant

and

U.S. POSTAL SERVICE, POST OFFICE, 

Oklahoma City, OK, Employer

__________________________________________

)

)

)

)

)

)

)

)

Docket No. 21-0945

Issued: March 16, 2022

Appearances: Case Submitted on the Record

Appellant, pro se

Office of Solicitor, for the Director

ORDER DISMISSING APPEAL

Before:

ALEC J. KOROMILAS, Chief Judge

JANICE B. ASKIN, Judge

VALERIE D. EVANS-HARRELL, Alternate Judge

On June 3, 2021 appellant filed a timely appeal from the December 8, 2020 OWCP 

decision, to which the Clerk of the Appellate Boards assigned Docket No. 21-0945.

By decision dated March 13, 2020, the Board set aside the December 3, 2018 OWCP 

decision and remanded the case for OWCP to apply the more stringent clear evidence of error 

standard for an untimely request for reconsideration.

In accordance with the Board’s March 13, 2020 decision, OWCP issued a December 8, 

2020 decision and denied appellant’s November 20, 2018 request for reconsideration of the merits 

of her claim, finding that it was untimely filed and failed to demonstrate clear evidence of error.

On March 7, 2022 the Board issued an order under Docket No. 19-1354, finding that the 

March 13, 2020 Board decision was void ab initio and of no effect. The Board reissued the 

decision on March 13, 2022, finding that appellant’s November 20, 2018 request for 

reconsideration was timely filed from the most recent merit decision dated March 13, 2018.

The Board, having duly considered the matter, notes that because the Board voided the 

prior decision under Docket No. 19-1354, OWCP had no jurisdiction to issue the December 8, 

2020 decision. Consequently, the December 8, 2020 decision is null and void.
2

Pursuant to 5 U.S.C. § 8149 and 20 C.F.R. §§ 501.2(c) and 501.3(a), the Board’s 

jurisdiction is limited to review of final adverse decisions of OWCP issued under the Federal 

Employees’ Compensation Act (FECA).1 As the December 8, 2020 decision is null and void, the 

appeal assigned Docket No. 21-0945 does not contain a final adverse decision over which the 

Board may properly take jurisdiction.2 Therefore, the Board finds that the appeal docketed as No. 

21-0945 is dismissed. Accordingly,

IT IS HEREBY ORDERED THAT the appeal docketed as No. 21-0945 is dismissed.

Issued: March 16, 2022

Washington, DC

Alec J. Koromilas, Chief Judge

Employees’ Compensation Appeals Board

Janice B. Askin, Judge

Employees’ Compensation Appeals Board

Valerie D. Evans-Harrell, Alternate Judge

Employees’ Compensation Appeals Board

1

5 U.S.C. § 8101 et seq.; 20 C.F.R. §§ 501.2(c) and 501.3(a).

2

See Order Dismissing Appeal, L.R., Docket No. 20-1447 (issued April7, 2021).
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 (the Report) by OptimumBank
Holdings, Inc. (the Company), I, Richard L. Browdy, Chief Financial Officer (Principal Accounting Officer) of the Company, certify, pursuant to 18 U.S.C.§ 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that, to my knowledge:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |     |  |                                           
|------------------ |  | --- |  | ------------------------------------------
|Date: May 14, 2009 |  | By: |  | /s/ Richard L. Browdy                     
|                   |  |     |  | Richard L. Browdy, Chief Financial Officer
EXHIBIT 23.2

Consent of Independent Registered Public Accounting Firm

The Board of Directors
   ZiLOG, Inc.:

We consent to the incorporation by reference in the registration statements (Nos. 333-108372, 333-114501, and 333-114503) on Form S-8 of ZiLOG,
Inc. (the Company) of our report dated March 29, 2005, with respect to the Company's consolidated statement of operations, stockholders' equity and
cash flows for the twelve months ended December 31, 2004, and the related financial statement schedule, which report appears in the March 31, 2007,
annual report on Form 10-K of the Company.



/s/ KPMG LLP

Mountain View, California
   June 22, 2007

---